Results 141 to 150 of about 67,441 (256)

Pyridine‐dicarbonitriles acceptor engineering in multi‐resonance thermally activated delayed fluorescence with hybridized short‐ and long‐range charge transfer for high‐performance electroluminescence

open access: yesFlexMat, EarlyView.
Pyridine‐dicarbonitrile units integrated into a multiple‐resonance core engineer the excited state through cooperative short‐range charge transfer (SRCT) and long‐range charge transfer (LRCT), thereby enhancing the spin‐flipping process. Abstract Multi‐resonance (MR) thermally activated delayed fluorescence (TADF) materials exhibit narrowband emission ...
Jing Sun   +9 more
wiley   +1 more source

Craniofacial Resection for Advanced Cutaneous Squamous Cell Carcinoma: Results From the 2nd International Collaborative Case‐Series

open access: yesHead &Neck, EarlyView.
ABSTRACT Background Robust outcome data for anterior skull base cutaneous squamous cell carcinoma (cSCC) are limited, particularly as emerging therapies reshape management. We evaluated survival and prognostic factors following craniofacial resection. Methods Retrospective multi‐institutional case‐series (1995–2015) of patients who underwent skull base
Michael J. C. Schachtel   +52 more
wiley   +1 more source

PAH-associated health risk from ultrafine particles: an urban field study. [PDF]

open access: yesAir Qual Atmos Health
Su WC, Lee J, Afshar M, Zhang K, Han I.
europepmc   +1 more source

PAHs CONTAMINATION AND PAHs-DEGRADING BACTERIA IN SURFACE WATER OF SEA AREA TO THE WEST OF XIAMEN

open access: yes, 2003
在厦门西海域设置6 个站位,于2001 年7 月和10 月两个航次对各站位表层水中多环芳烃(PAHs) 的含量及几种常见PAHs 的降解菌的数量进行调查,结果表明:表层水中PAHs 的含量很不稳定,存在明显的时间变化。在7 月的调查中,表层水中能检测到的PAHs 以2 —3 环的为主,而在10 月以4 —6 环的为主。低分子量的PAHs —芴和菲的含量与其降解菌的数量之间具有明显的正相关,而高分子量的PAHs —荧蒽和芘的含量与其降解菌的数量之间没有表现出相关性。国家自然科学基金项目(30070157)
肖清江   +4 more
core  

Maternal and perinatal outcomes of pregnant women with echocardiographically high probability of pulmonary arterial hypertension

open access: yesInternational Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective This study aimed to describe maternal and perinatal outcomes among pregnant women with echocardiographically high probability of pulmonary arterial hypertension (PAH) managed at a quaternary center and to compare outcomes between women with and without cardiac complications (CC).
Laura Belmont‐Rojo   +6 more
wiley   +1 more source

The Endothelial CXCR Family in Vascular Health and Disease

open access: yesiNew Medicine, EarlyView.
ABSTRACT Endothelial cells (ECs) form the dynamic interface between blood and tissue, serving as key regulators of vascular homeostasis, inflammation, and repair. Among the molecular systems governing endothelial behavior, the C‐X‐C motif chemokine receptor (CXCR) family—originally characterized in immunology for its roles in leukocyte trafficking and ...
Zhiming Wu   +4 more
wiley   +1 more source

Traditional Chinese Medicine and Natural Products Targeting Right Ventricular Dysfunction in Pulmonary Arterial Hypertension: Toward Precision Cardiometabolic Therapy

open access: yesiNew Medicine, EarlyView.
Natural products and traditional Chinese medicine target metabolic pathways underlying right ventricular dysfunction in pulmonary arterial hypertension. Integrating multi‐omics, artificial intelligence, and systems biology may enable precision cardiometabolic therapies to restore right ventricular metabolism and improve clinical outcomes.
Yihao Wu, Zhehui Tang, Hongwei Yao
wiley   +1 more source

S100A9 promotes pulmonary arterial hypertension by regulating mitochondria–endoplasmic reticulum interaction‐mediated inflammatory injury of endothelial cells

open access: yesInterdisciplinary Medicine, EarlyView.
Macrophage‐derived S100 calcium‐binding protein A9 (S100A9) promotes the pathological progression of pulmonary arterial hypertension (PAH). S100A9 upregulates the interaction between signal‐transducing adaptor protein 2 and leucine‐rich repeat kinase 2, thereby regulating mitochondria–endoplasmic reticulum (ER) contact.
Chen Gong   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy